As the calendar turns to 2022, the slate is wiped clean of the buoyant enthusiasm that carried risk markets higher through the second half of 2020 and all of 2021. Aggressive fiscal stimulus is now in the rearview mirror, while central banks globally have begun to roll back asset purchases – and in some cases – aggressively raise interest rates to combat persistently high inflation.
The emergence of the Omicron variant may ultimately portend the end of the pandemic as we know it, but the threat of overwhelmed healthcare systems, even if fatalities remain low, could bring about more government restrictions that weigh on economic activity. At least for 1Q’22, these factors could see a further cooling of risk appetite before calmer – and more bullish – heads prevail later in the year.
S&P 500 vs. Nasdaq 100 (SPX/NAS) Technical Analysis: Daily Chart (January 2020 to December 2021)
When the 4Q’21 top opportunities were written, the US S&P 500[1] was trading below 4450, and a year-end target of 4800 was outlined. Stocks nearly achieved that goal, hitting a high of 4731 by mid-December. But there has been a notable shift in the internals of the market: the high flying, high growth, low (or no) revenue tech names have slumped significantly.
And thus in lies the rub for early-2022: growth stocks may continue to underperform their value counterparts. The S&P 500/Nasdaq[2] 100 ratio broke its downtrend in place from May through December by mid-December 2021, with a potential double bottom forming against the 1Q’21 and 4Q’21 lows. With the breakout higher just having transpired in the past few weeks, we may be in the early stages of a rotation in stocks from growth to value. The long S&P 500/short Nasdaq 100 trade is
